What is Viking Therapeutics's asset turnover?

Viking Therapeutics (VKTX) reported asset turnover of 0× in Q1 2026.

What does asset turnover mean?

Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Viking Therapeutics VKTX Asset turnover

Asset turnover at other companies

Eli LillyLLY

0.7×+0.1×

PfizerPFE

0.3×0.0×

AmgenAMGN

0.4×0.0×

Madrigal Pharmaceuticals, Inc.MDGL

1×+0.7×

Crinetics PharmaceuticalsCRNX

0×0.0×

Relay Therapeutics, Inc.RLAY

0×0.0×

Other financials

Income statement

See full

Revenue-—

Operating income-$164.1M-196%

Net income-$158.3M-247%

EPS (diluted)-$1.37-234%

Balance sheet

See full

Cash & equivalents$118.1M+211%

Total debt$137.0K-87.8%

Total equity$501.9M-40.7%

Total assets$608.2M-29.8%

Cash flow

See full

Operating cash flow-$114.0M-118%

Valuation

See full

Market cap$4.04B+38.7%

Returns & leverage

See full

Return on equity-70%-94.5pp

Debt / equity0×0.0×

Current ratio5.7×-38.5×

Where this comes from

Calculated from Viking Therapeutics’s reported figures.

total revenue/total assets=0×

Based on trailing twelve months.

The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viking Therapeutics's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viking Therapeutics's asset turnover?: Viking Therapeutics (VKTX) reported asset turnover of 0× in Q1 2026.
What does asset turnover mean?: Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.